參考文獻（上下滑動查看）

[1] Lyden PD. Cerebroprotection for acute ischemic stroke: looking ahead[J]. Stroke. 2021;52:3033-3044.

[2]Marc Fisher, Sean I Savitz.Pharmacological brain cytoprotection in acute ischaemic stroke - renewed hope in the reperfusionera[J].Nat Rev Neurol,2022,18(4):193-202.

[3]Yunyun Xiong, Ajay K Wakhloo, Marc Fisher.Advances in Acute Ischemic Stroke Therapy[J].Circ Res,2022,130(8):1230-1251.

[4] 中國老年醫(yī)學(xué)學(xué)會腦血管病分會. 缺血性卒中腦細胞保護臨床實踐中國專家共識 [J]. 國際神經(jīng)病學(xué)神經(jīng)外科學(xué)雜志，2025，52（2）：1-7.

[5]William J. Powers,Alejandro A. Rabinstein,Teri Ackerson,et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association[J]. Stroke,2019,50(12):e344-e418.

[6]Saver JL, Starkman S, Eckstein M, et al.FAST-MAG Investigators and Coordinators. Prehospital use of magnesium sulfate as neuroprotection in acute stroke[J]. N Engl J Med. 2015;372:528-536.

[7]Patrick D Lyden.Cerebroprotection for Acute Ischemic Stroke: Looking Ahead[J].Stroke,2021,52(9):3033-3044.

[8] 賈敏，梁曉，付國靜，等. 理洫王. 血塞通軟膠囊臨床應(yīng)用專家共識 [J]. 中國中藥雜志，2023，48（20）：5668-5674.

[9] 李建章, 張杰文, 劉恒方. 慢性腦缺血臨床診治專家共識 [J]. 中國實用神經(jīng)疾病雜志，2022，25（6）：661-667.

關(guān)注“鐘書醫(yī)生”公眾號：專治腦血管病，科普醫(yī)學(xué)知識，追求文明生活!

來源：丁香園神經(jīng)時間